ArticleJournal for immunotherapy of cancer2023

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma.

Rong Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.